6,318 results on '"APPETITE loss"'
Search Results
2. Role of Transcranial Direct Current Stimulation in Appetite and Weight Control (TDCS)
- Author
-
Harvard Medical School (HMS and HSDM) and Paresh Dandona, SUNY Distinguished Professor
- Published
- 2024
3. Beneficial effect of oral semaglutide for type 2 diabetes mellitus in patients with metabolic dysfunction‐associated steatotic liver disease: A prospective, multicentre, observational study.
- Author
-
Arai, Taeang, Atsukawa, Masanori, Tsubota, Akihito, Oikawa, Tsunekazu, Tada, Toshifumi, Matsuura, Kentaro, Ishikawa, Toru, Abe, Hiroshi, Kato, Keizo, Morishita, Asahiro, Tani, Joji, Okubo, Tomomi, Nagao, Mototsugu, Iwabu, Masato, and Iwakiri, Katsuhiko
- Subjects
- *
TYPE 2 diabetes , *HEPATIC fibrosis , *APPETITE loss , *GLYCEMIC control , *SEMAGLUTIDE - Abstract
Aims Materials and Methods Results Conclusions To evaluate the efficacy and safety of oral semaglutide for type 2 diabetes mellitus (T2DM) in patients with metabolic dysfunction‐associated steatotic liver disease (MASLD).This was a single‐arm, multicentre, prospective study. Among 80 consecutive patients with MASLD and T2DM who newly received oral semaglutide, 70 completed 48‐week oral semaglutide treatment as scheduled and were included in an efficacy analysis. Dose adjustments of oral semaglutide were determined by each physician while monitoring efficacy and adverse events.Significant improvements in body weight, liver enzymes, lipid profile, and glycaemic control were found at 48 weeks compared with baseline values (all p < 0.01). Controlled attenuation parameter values significantly decreased from baseline to 48 weeks (p < 0.01). Changes in alanine aminotransferase concentrations (r = 0.37, p < 0.01) and controlled attenuation parameter values (r = 0.44, p < 0.01) were significantly correlated with changes in body weight. Liver fibrosis markers, such as type IV collagen 7S, Wisteria floribunda agglutinin‐positive Mac‐2‐binding protein, fibrosis‐4 index, and liver stiffness measurement, significantly decreased from baseline to 48 weeks (all p < 0.01). The most common adverse events were Grades 1–2 transient gastrointestinal symptoms, such as nausea (23 patients, 28.8%), dyspepsia (12, 15.0%) and appetite loss (4, 5.0%).Oral semaglutide treatment for T2DM in patients with MASLD leads to an improvement in liver steatosis and injury, surrogate markers of fibrosis, diabetic status, and lipid profile, and reduces body weight. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
4. Pediatric Oropharyngeal Tularemia Cases: Challenges in Management.
- Author
-
Kara, Soner Sertan, Polat, Meltem, Erdeniz, Emine Hafize, and Donmez, Ayşe Sena
- Subjects
FRANCISELLA tularensis ,CONSCIOUSNESS raising ,TULAREMIA ,LEUKOCYTE count ,APPETITE loss - Abstract
Background: Tularemia is one of the most prevalent zoonoses across the world. Patients in Turkiye mostly contract the oropharyngeal form, acquired through drinking, or contact with microorganism-contaminated water. Methods: Patients with oropharyngeal tularemia aged under 18 years and diagnosed between January 01, 2017, and December 31, 2020, were evaluated retrospectively. Tularemia was diagnosed in patients with compatible histories, symptoms, clinical presentations, and laboratory test results. Results: The mean age of 38 children was 12.1 ± 3.4 years, and the female/male ratio was 0.58 (14/24). The mean duration of symptoms on admission was 33.8 ± 26.2 days. All children had enlarged lymph nodes. Malaise, fever, and loss of appetite were other frequent symptoms. Patients were treated with antibiotics for a mean of 26.2 ± 18.8 days. Gentamycin was the most frequently used antibiotic (either alone or in combination) (n = 29, 76.3%). Twenty-six (68.4%) patients underwent surgical procedures in addition to antibiotherapy. Five (13.2%) required secondary total excision. Patients with higher leukocyte counts at admission received a combination of antibiotherapy plus surgery, rather than antibiotics alone. No relapses, reretreatment requirement, or mortality were observed after 12 months of follow-up. Conclusions: Oropharyngeal tularemia in children can require longer courses of antibiotic treatment with more than one drug and more frequent surgery than previously suggested in the literature, especially if the patients are admitted late to the hospital, symptom duration is prolonged, and appropriate treatment is initiated late. Higher leukocyte counts on admission may be prognostic for longer antibiotic treatment course and suppurative complications that require surgery. Raising awareness among patients and physicians is essential. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
5. Exploring the molecular tapestry of <italic>Sarcodon</italic> secondary metabolites: chemical structures, activities, and biosynthesis.
- Author
-
Liu, Yu-Ying, Zhang, Ming, Tang, Fei, Wang, Hai-Qiang, Gao, Jin-Ming, Li, Minglei, and Qi, Jianzhao
- Subjects
- *
DRUG discovery , *METABOLITES , *APPETITE loss , *SECONDARY research , *CHEMICAL structure - Abstract
Sarcodon mushrooms are esteemed as a rare and highly valuable resource for both culinary and medicinal purposes. Ancient medical classics have documented their beneficial effects on conditions such as indigestion, loss of appetite, and neurological disorders. Modern phytochemical research into their secondary metabolites has led to the discovery of numerous bioactive compounds with significant biological activities. Despite notable achievements in the study of the chemical composition and bioactivity ofSarcodon mushrooms, a comprehensive understanding of these findings has been lacking. This review provides an exhaustive summary of the advancements in the phytochemistry ofSarcodon mushrooms, as well as the biological and pharmacological activities of the isolated compounds and crude extracts derived fromSarcodon over the past nine decades. A total of 100 secondary metabolites isolated from these mushrooms have been classified into five major categories based on their chemical structures, which exhibit bioactivities such as anti-tumour, neurotrophic, and neuroprotective, antioxidant, anti-inflammatory, antimicrobial, and hypoglycaemic properties. The aim of this study is to establish a scientific foundation for future research in drug discovery, biotechnological development, and the exploration of functional foods involvingSarcodon mushrooms. [ABSTRACT FROM AUTHOR]- Published
- 2024
- Full Text
- View/download PDF
6. Etoposide, cisplatin, and sintilimab combined with anlotinib in successful treatment of adrenocortical carcinoma with lung metastasis: a case report.
- Author
-
Wenjing Niu, Haimei Zhang, Xuezhen Ma, Hua Liang, Zhongshi Qiao, Zheng Wang, and Lifeng Niu
- Subjects
ANLOTINIB ,ADRENAL cortex ,APPETITE loss ,PROGRESSION-free survival ,CISPLATIN - Abstract
Background: Adrenocortical carcinoma (ACC) is a rare malignant tumor that occurs in the adrenal cortex. It has a high degree of malignancy and comparatively poor overall prognosis. Surgery is the standard curative therapy for localized ACC patients. The combination regimen of etoposide, doxorubicin, cisplatin (EDP) plus mitotane has been considered as the standardized chemotherapy regimen for advanced ACC. However, new effective regimens are emerging for specific conditions in metastatic ACC. Case presentation: We report a case of a 66-year-old man diagnosed with metastatic ACC who had a large left adrenal mass (110 mm × 87 mm) and multiple metastases in both lungs. The patient was treated with EP and sintilimab for six cycles; anlotinib was introduced after the third cycle. Follow-ups after the second to fourth cycles found significantly reduced lung metastases with all imaging examinations indicating partial response (PR) status. The patient received maintenance therapy thereafter with sintilimab plus anlotinib. Until recently, the patient’s lung metastases and the left adrenal gland area mass (39mm × 29mm) have disappeared, and no disease progression has been observed. The progression-free survival of this patient has been extended to approximately 31 months, in sharp contrast to a median survival time of 12 months for majority of advanced ACC. The main adverse events during treatment were appetite loss and grade I myelosuppression and revealed only grade I hypertension and grade I hypothyroidism. Conclusion: This case highlights the remarkable response of our patient’s ACC to treatment with a novel combination of EP and sintilimab combined with anlotinib. Our findings suggest a safe and more effective combination therapeutic option for patients with adrenocortical carcinoma. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
7. Circulating endocannabinoidome signatures of disease activity in amyotrophic lateral sclerosis.
- Author
-
Dubbioso, Raffaele, Iannotti, Fabio Arturo, Senerchia, Gianmaria, Verde, Roberta, Iuzzolino, Valentina Virginia, Spisto, Myriam, Fasolino, Ines, Manganelli, Fiore, Di Marzo, Vincenzo, and Piscitelli, Fabiana
- Subjects
- *
AMYOTROPHIC lateral sclerosis , *APPETITE loss , *CLUSTER analysis (Statistics) , *INDIVIDUALIZED medicine , *NEUROLOGICAL disorders - Abstract
Background and purpose Methods Results Conclusion Preclinical studies of amyotrophic lateral sclerosis (ALS) have shown altered endocannabinoid (eCB) signalling that may contribute to the disease. Results from human studies are sparse and inconclusive. The aim of this study was to determine the association between serum levels of eCBs or their congeners, the so‐called endocannabinoidome, and disease status and activity in ALS patients.Serum concentrations of 2‐arachidonoylglycerol and N‐arachidonoylethanolamine (AEA), and AEA congeners palmitoylethanolamide (PEA), oleoylethanolamide (OEA), eicosapentaenoylethanolamide (EPEA), 2‐docosahexaenoylglycerol (2‐DHG) and docosahexaenoylethanolamide (DHEA) were measured in samples from 65 ALS patients, 32 healthy controls (HCs) and 16 neurological disease controls (NALS). A subset of 46 ALS patients underwent a longitudinal study. Disease activity and progression were correlated with eCB and congener levels.Most circulating mediators were higher in ALS than HCs (all p < 0.001), but not NALS. Across clinical stages, ALS patients showed increased levels of PEA, OEA and EPEA (all p < 0.02), which were confirmed by the longitudinal study (all p < 0.03). Serum PEA and OEA levels were independent predictors of survival and OEA levels were higher in patients complaining of appetite loss. Cluster analysis revealed two distinct profiles of circulating mediators associated with corresponding patterns of disease activity (severe vs. mild). Patients belonging to the ‘severe’ cluster showed significantly higher levels of OEA and PEA and lower levels of 2‐DHG compared to NALS and HCs.Circulating endocannabinoidome profiles are indicative of disease activity, thus possibly paving the way to a personalized, rather than a ‘one‐fits‐all’, therapeutic approach targeting the endocannabinoidome. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
8. Characteristics and pathogenicity of Vibrio alginolyticus SWS causing high mortality in mud crab (Scylla serrata) aquaculture in Hong Kong.
- Author
-
Tsun-Ka Kwok, Carsten, Chun-Wai Yu, Ray, Pak-Ting Hau, Yuen-Ching Cheung, Karry, Chi-Fung Ng, Iain, Fung, Joshua, Tak-Fai Wong, Ivan, Chong-Yee Yau, Miranda, Wai-Man Liu, Hang-Kin Kong, Kit-Hang Siu, Gilman, Wang-Ngai Chow, Franklin, and Sai-Wang Seto
- Subjects
SCYLLA (Crustacea) ,SCYLLA serrata ,VIBRIO alginolyticus ,MICROBIAL sensitivity tests ,APPETITE loss - Abstract
Introduction: Vibrio alginolyticus is a Gram-negative, rod-shaped bacterium belonging to the family of Vibrionaceae, a common pathogen in aquaculture animals, However, studies on its impact on Scylla serrata (mud crabs) are limited. In this study, we isolated V. alginolyticus SWS from dead mud crab during a disease outbreak in a Hong Kong aquaculture farm, which caused up to 70% mortality during summer. Methods: Experimental infection and histopathology were used to investigate the pathogenicity of V. alginolyticus SWS in S. serrata and validate Koch's postulates. Comprehensive whole-genome analysis and phylogenetic analysis antimicrobial susceptibility testing, and biochemical characterization were also performed. Results: Our findings showed that V. alginolyticus SWS caused high mortality (75%) in S. serrata with infected individuals exhibiting inactivity, loss of appetite, decolored and darkened hepatopancreas, gills, and opaque muscle in the claw. Histopathological analysis revealed tissue damage and degeneration in the hepatopancreas, gills, and claw muscle suggesting direct and indirect impacts of V. alginolyticus SWS infection. Conclusions: This study provides a comprehensive characterization of V. alginolyticus SWS as an emerging pathogen in S. serrata aquaculture. Our findings underscore the importance of ongoing surveillance, early detection, and the development of targeted disease management strategies to mitigate the economic impact of vibriosis outbreaks in mud crab aquaculture. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
9. Health‐related quality of life in older hematological cancer survivors (70+) compared to older general population—A German cancer‐register‐based cross‐sectional comparative study.
- Author
-
Schatz, Florian, Mehnert‐Theuerkauf, Anja, Platzbecker, Uwe, Springer, Franziska, and Götze, Heide
- Subjects
- *
SYMPTOM burden , *MULTIPLE regression analysis , *GERIATRIC oncology , *APPETITE loss , *OLDER patients , *PSYCHO-oncology - Abstract
Objectives Materials and Methods Results Discussion The extent of health‐related quality of life (HRQOL) impairments in older hematological cancer survivors (HCS) has not been sufficiently studied. We therefore examined HRQOL in older HCS compared to a community sample (CS) and investigated sociodemographic, disease‐ and treatment‐specific, geriatric, and psychosocial factors associated with reduced HRQOL.In this cancer‐register‐based cross‐sectional comparative study 200 HCS, aged ≥70 years, and 252 persons of an age‐ and gender‐matched CS completed validated questionnaires including the EORTC QLQ‐C30 and EORTC QLQ‐ELD14.Older HCS reported a reduced HRQOL in the dimensions of global QOL, physical, role, and social functioning (small clinical significance) and higher symptom burden of fatigue, nausea and vomiting, appetite loss, and poorer mobility compared to the CS (fatigue and mobility with medium, the others with small clinical significance). Perceived disease burden of comorbidities, functional disabilities, psychological distress, and depression showed statistical significance for reduced HRQOL in older HCS in multiple linear regression analysis (R2 = .602, p < .001).The screening and treatment of functional limitations and individual symptoms and the integration of a geriatric assessment into oncological practice can help to identify supportive care needs, to implement individualized, patient‐centered cancer survivorship care programs and to improve older HCS's HRQOL. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
10. The quality of life outcome in patients with head and neck squamous cell cancer treated using chemoradiotherapy.
- Author
-
Tsukada, Kazuya, Seino, Yutomo, and Yamashita, Taku
- Subjects
- *
SQUAMOUS cell carcinoma , *QUALITY of life , *TREATMENT effectiveness , *APPETITE loss , *CHEMORADIOTHERAPY , *CANCER fatigue - Abstract
Organ preservation is a goal of head and neck squamous cell cancer (HNSCC) treatment. chemoradiotherapy remains one of the main treatment options and is widely recognized as a method with organ-preserving potential and outcomes comparable to those of surgery. However, few studies have investigated the quality of life (QOL) of patients with HNSCC treated using chemoradiotherapy, therefore, we aimed to retrospectively evaluate how QOL changes pre and post-chemoradiotherapy. We evaluated QOL outcomes in patients who underwent initial radical chemoradiotherapy for HNSCC at the Department of Otolaryngology and Head and Neck Surgery Kitasato University Hospital from 2018 to 2021. We used the Cancer Fatigue Scale (CFS) and the combined European Organization for Research and Treatment of Cancer (EORTC) QLQ-C30 and QLQ-H&N35 questionnaires at pre-treatment, three months and six months post-treatment. We obtained 37 and 29 responses from the CFS and EORTC QLQ-C30/H&N35 questionnaire, respectively. From the CFS, the physical fatigue score at three months post-treatment deteriorated more than that at pre-treatment, and significantly improved by six months post-treatment. The total score worsened significantly at three months and there was a trend toward improvement at six months. In the EORTC QLQ-C30, physical and social functioning declined in three months and did not improve within six months. Fatigue was substantially worse at three months and significantly improved at six months but did not reach the same level as that before treatment. Appetite loss was also significantly worse at three months. In the QLQ-H&N35 questionnaire, sensory issues, trouble with social contact, and dry mouth were significantly worse at three months and did not improve within six months. Sticky saliva also worsened at three months and significantly improved at six months. There were some problems associated with chemoradiotherapy. Some patients showed an improvement, while others continued to have challenges. In Japan, chemoradiotherapy was shown to have a long-term impact on the patient's life. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
11. Current situation and future issues with Kampo medicine: A survey of Japanese physicians.
- Author
-
Uneda, Kazushi, Yoshino, Tetsuhiro, Ito, Hidenori, Imoto, Seiya, and Nogami, Tatsuya
- Subjects
- *
ASIAN medicine , *MEDICAL education , *APPETITE loss , *MEDICAL software , *MEDICALLY unexplained symptoms ,JAPANESE herbal medicine - Abstract
Aim: We aimed to elucidate the present clinical situation, future challenges, and potential need for diagnostic support software in Kampo medicine. Methods: We conducted an online survey (comprising 28 questions) of Japanese physicians from the 23 to 24 January 2024 via MedPeer. The participants' responses were stratified according to their age distribution. Results: We evaluated data for 652 respondents. The most common respondent age groups were those in their 30s and 40s. The most common specialty of respondents was internal medicine (43.7%). Only 33.7% of respondents had received education on Kampo medicine at university. Most respondents (90.0%) were not licensed as certified physicians or members of the Japan Society for Oriental Medicine. Most respondents (86.7%) currently prescribed Kampo formulas (current users); only 3.8% had no experience in prescribing Kampo formulas. The conditions for which Kampo formulas were frequently prescribed were muscle cramps, constipation, medically unexplained symptoms/menopausal syndrome, appetite loss/malnutrition, and fatigue. However, 48.3% of current users did not use traditional Kampo patterns (sho). The most frequent issues reported by respondents were the lack of scientific evidence and standardization of diagnostic methods in Kampo medicine. Respondents indicated the need for postgraduate education and implementation of diagnostic support software for using Kampo patterns by non‐specialists in Kampo medicine. Conclusion: There was a discrepancy between the high frequency of Kampo formula prescriptions and the low use of traditional Kampo patterns in Japan. Diagnostic support software is likely to become a useful method of improving appropriate Kampo formula prescriptions by non‐specialists. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
12. Definitive radio(chemo)therapy versus upfront surgery in the treatment of HPV-related localized or locally advanced oropharyngeal squamous cell carcinoma.
- Author
-
Baude, Jérémy, Guigou, Caroline, Thibouw, David, Vulquin, Noémie, Folia, Mireille, Constantin, Guillaume, Boustani, Jihane, Duvillard, Christian, Ladoire, Sylvain, Truc, Gilles, Bertaut, Aurélie, and Chevalier, Cédric
- Subjects
- *
SQUAMOUS cell carcinoma , *RADIOISOTOPE brachytherapy , *END of treatment , *APPETITE loss , *CETUXIMAB , *ORAL habits , *OVERALL survival , *PROGRESSION-free survival - Abstract
Background: The treatment of stage I-III HPV+ oropharyngeal squamous cell carcinoma (HPV-OPSCC) is based on either surgery ± adjuvant therapy or exclusive radio±chemotherapy. We sought to compare these two therapeutic strategies in terms of efficacy, tolerance and quality of life (QoL). Methods: Patients treated for stage I-III HPV-OPSCC from 2010 to 2021 in 3 academic centers were included and sorted according to the treatment strategy: surgery or exclusive radio±chemotherapy. Efficacy and tolerance were retrospectively assessed, and a transversal exploratory QoL assessment was performed using QoL instruments. Results: A total of 83 patients were included, with 21 undergoing non-minimally invasive surgery and 62 receiving definitive radio-±chemotherapy. 2-year progression-free survival (PFS) and overall survival (OS) were respectively 80% and 86% in the surgical group and 92% and 95% in the non-surgical group, with no significant difference. At the end of treatment, 64.5% of patients presented with a grade III toxicity, without significant difference between the two groups. No patient had late grade III toxicity at 24 months. Forty-five patients (11 in the surgical group, 34 in the non-surgical group) participated in an exploratory quality-of-life analysis. Patients reported significantly more fatigue and loss of appetite after surgery, whereas patients in the radio±chemotherapy group described significantly more salivary and oral problems and difficulty swallowing, but the median time between treatment completion and the response to the questionnaires. Conclusion: There was no significant difference in efficacy, physician-reported toxicity and overall patient-reported quality of life was found between non-minimally invasive surgery and radio±chemotherapy in the treatment of stage I-III HPV-OPSCC. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
13. From pregnancy to the postpartum: Unraveling the complexities of symptom profiles among trauma-exposed women.
- Author
-
Miller, Michelle L., Laifer, Lauren M., Thomas, Emily B.K., Grekin, Rebecca, O'Hara, Michael W., and Brock, Rebecca L.
- Subjects
- *
POST-traumatic stress disorder , *MEDICAL personnel , *MENTAL health screening , *PERINATAL period , *APPETITE loss , *PREGNANCY - Abstract
Many women experience new onset or worsening of existing posttraumatic stress disorder (PTSD) symptoms during pregnancy and the early postpartum period. However, perinatal PTSD symptom profiles and their predictors are not well understood. Participants (N = 614 community adults) completed self-report measures across three methodologically similar longitudinal studies. Mixture modeling was used to identify latent subgroups of trauma-exposed women with distinct patterns of symptoms at pregnancy, 1-month, and 3-month postpartum. Mixture modeling demonstrated two classes of women with relatively homogenous profiles (i.e., low vs. high symptoms) during pregnancy (n = 237). At 1-month postpartum (n = 391), results suggested a five-class solution: low symptoms, PTSD only, depression with primary appetite loss, depression, and comorbid PTSD and depression. At 3-months postpartum (n = 488), three classes were identified: low symptoms , elevated symptoms, and primary PTSD. Greater degree of exposure to interpersonal trauma and reproductive trauma, younger age, and minoritized racial/ethnic identity were associated with increased risk for elevated symptoms across the perinatal period. Only a subset of potential predictors of PTSD symptoms were examined. Replication with a larger and more racially and ethnically diverse sample of pregnant women is needed. Results highlight limitations of current perinatal mental health screening practices, which could overlook women with elevations in symptoms (e.g., intrusions) that are not routinely assessed relative to others (e.g., depressed mood), and identify important risk factors for perinatal PTSD symptoms to inform screening and referral. • Perinatal posttraumatic stress disorder (PTSD) symptoms are understudied. • The elevated symptom profile during pregnancy demonstrated homogeneity. • PTSD symptoms were differentiated across profiles during the postpartum period. • Interpersonal/reproductive trauma, age, and race/ethnicity predicted increased risk. • Perinatal PTSD symptoms should be routinely assessed by health care professionals. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
14. PARACOCCIDIOIDOMICOSE, UM CASO RARO DE ICTERÍCIA OBSTRUTIVA.
- Author
-
Jorge Pareja, Helen Brambila, Shono Maehara, Maria Eduarda, Lex da Motta, Lorena, Denepotti Nogueira, Vinicius, and Vedove Rosa, Guilherme Dale
- Subjects
BILIARY tract ,RURAL population ,BILE ducts ,PARACOCCIDIOIDOMYCOSIS ,APPETITE loss - Abstract
Copyright of Revista Foco (Interdisciplinary Studies Journal) is the property of Revista Foco and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
- Published
- 2024
- Full Text
- View/download PDF
15. ADENOCARCINOMA GÁSTRICO COM ANEL EM SINETE.
- Author
-
Jorge Pareja, Helen Brambila, Parizoto Fabrin, Rafaela, Vedove Rosa, Guilherme Dale, and Shono Maehara, Maria Eduarda
- Subjects
APPETITE loss ,STOMACH cancer ,GASTRECTOMY ,CAUSES of death ,ABDOMINAL pain - Abstract
Copyright of Revista Foco (Interdisciplinary Studies Journal) is the property of Revista Foco and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
- Published
- 2024
- Full Text
- View/download PDF
16. Quality-of-life outcomes in metastatic spinal cord compression: findings from the SCORAD trial.
- Author
-
Hoskin, Peter J, Reczko, Krystyna, Rashid, Memuna, Hackshaw, Allan, Lopes, Andres, and Investigators, the SCORAD
- Subjects
- *
SPINAL cord compression , *QUALITY of life , *APPETITE loss , *PHYSICAL mobility , *METASTASIS - Abstract
Purpose This article reports detailed quality-of-life data including preferred and actual place of care from SCORAD, the only large prospective randomized trial in metastatic spinal cord compression (MSCC). Methods SCORAD compared 2 doses of radiotherapy in patients with MSCC: 8 Gy single fraction and 20 Gy in 5 fractions. In total, 686 patients were randomized, of whom 590 had Health-Related Quality of Life (HRQoL) data collected at baseline and at least 1 later time point. HRQoL was measured using the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire–Core 30 supplemented with the QLU-C10D and data on place of care at weeks 1, 4, 8, and 12 postrandomization. Quality-of-Life Adjusted Survival was computed by multiplying Kaplan-Meier survival probabilities with the UK utility weights obtained from the QLU-C10D. Results Patients with a baseline physical functioning score of above 50 demonstrated a 28% reduction in the risk of death (hazard ratio [HR] = 0.72, 99% confidence interval [CI] = 0.54 to 0.95; P = .003). An increased risk of death was associated with fatigue (HR = 1.35, 99% CI = 1.03 to 1.76; P = .0040), dyspnea (HR = 1.61, 99% CI = 1.24 to 2.08; P < .001), and appetite loss (HR = 1.25, 99% CI = 0.99 to 1.59; P = .014). The preferred place of care for the majority was at home or with relatives (61%-74% across the 12 weeks) but achieved by only 53% at 8 weeks. Conclusions Prolonged survival in patients with MSCC was associated with better HRQoL. More than 60% of patients preferred to be cared for at home or with relatives, but only half were able to achieve this. There was no difference in HRQoL between the multifraction and single-fraction groups. Trial registration ISRCTN97555949 and ISRCTN97108008. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
17. Rotavirus Sickness Symptoms: Manifestations of Defensive Responses from the Brain.
- Author
-
Hellysaz, Arash and Hagbom, Marie
- Subjects
- *
APPETITE loss , *CENTRAL nervous system , *FATIGUE (Physiology) , *ROTAVIRUSES , *SMALL intestine - Abstract
Rotavirus is infamous for being extremely contagious and for causing diarrhea and vomiting in infants. However, the symptomology is far more complex than what could be expected from a pathogen restricted to the boundaries of the small intestines. Other rotavirus sickness symptoms like fever, fatigue, sleepiness, stress, and loss of appetite have been clinically established for decades but remain poorly studied. A growing body of evidence in recent years has strengthened the idea that the evolutionarily preserved defensive responses that cause rotavirus sickness symptoms are more than just passive consequences of illness and rather likely to be coordinated events from the central nervous system (CNS), with the aim of maximizing the survival of the individual as well as the collective group. In this review, we discuss both established and plausible mechanisms of different rotavirus sickness symptoms as a series of CNS responses coordinated from the brain. We also consider the protective and the harmful nature of these events and highlight the need for further and deeper studies on rotavirus etiology. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
18. Journeying together: spousal experiences with prostate cancer in Ghana.
- Author
-
Appiah, Evans Osei, Oti-Boadi, Ezekiel, Amertil, Ninon P., Afotey, Rosina, Lavoe, Honest, Garti, Isabella, Menlah, Awube, and Ntiako Sekyi, Eric Kwesi
- Subjects
- *
PROSTATE cancer , *SLEEP interruptions , *APPETITE loss , *WELL-being , *LEG pain , *SMELL - Abstract
Background: Prostate cancer (PCa) is a significant global health concern for men. In SubSaharan Africa, PCa rates witnessed a 69% increase from 1990 to 2010. Despite this, there is a dearth of literature examining the experiences of spouses of men with PCa in Africa, as the majority of studies concentrate primarily on men. Methods: The study used a qualitative exploratory design, conducting in-depth face-to-face interviews with a semi-structured guide. Participants were selected through purposive sampling, with 35 recruited. Data was recorded, transcribed verbatim, and analysed using content analysis, resulting in 3 themes and 18 subthemes. Results: The research revealed that spouses providing care for husbands with PCa faced notable effects on their physical and emotional well-being. Notably, they reported experiencing leg pains due to prolonged sitting by their partners, as well as disruptions in sleep and a loss of appetite triggered by the hospital smell. Conclusion: Women encounter challenges in caring for their partners with PCa. Understanding these experiences will contribute to improving public support and assistance. Future studies should concentrate on developing interventions to help them cope with these challenges. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
19. Enterolith with a bonefish spine nidus in a Brazilian cownose ray Rhinoptera brasiliensis (Müller & Henle) (Myliobatiformes: Rhinopteridae).
- Author
-
Camilo, L. O., Maganhe, B. L., Gallo Neto, H., and Sanches, E. G.
- Subjects
- *
AUTOPSY , *SPINE , *FOREIGN bodies , *APPETITE loss , *STINGRAYS - Abstract
An adult female Brazilian cownose ray (Rhinoptera brasiliensis), housed in Ubatuba Aquarium died after loss of appetite period. During necropsy, an enterolith was discovered partially obstructing the intestinal lumen. Examination of the enterolith revealed a bonefish spine nidus. Enterolithiasis has been linked to multiple factors including diet, genetics, alkaline intestinal environments and, as in this particular case, the ingestion and retention of foreign bodies. The composition of this enterolith from a cownose ray was primarily monohydrocalcite. This short communication, apparently the first to report enterolithiasis in stingrays, emphasizes the need for post‐mortem examinations of carcasses on macroscopic and microscopic levels. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
20. SÍNDROME DA DOR TOTAL: UMA REVISÃO DE LITERATURA.
- Author
-
de Oliveira Gonçalves, Djalma Igor, Boas Marinho, Alice Vilas, Figueiredo Faria, Arthur, and Fayssander Norbim, Enzzo
- Subjects
SLEEP interruptions ,LITERATURE reviews ,MENTAL health ,PALLIATIVE treatment ,APPETITE loss - Abstract
Copyright of Revista Foco (Interdisciplinary Studies Journal) is the property of Revista Foco and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
- Published
- 2024
- Full Text
- View/download PDF
21. The Effect of Cannabis in Pancreatic Cancer
- Author
-
Jens Rikardt Andersen, Associate Professor
- Published
- 2023
22. Virtual Reality at End-of-life
- Author
-
State University of New York - Upstate Medical University and Catherine Mann, Clinical Professor
- Published
- 2023
23. Effect of a Novel Protein Supplement on Appetite in Older Adults
- Author
-
FHI 360 and Katy Horner, Lecturer in Sport and Exercise Science
- Published
- 2023
24. Molecular surveillance for dengue serotypes among the population living in Moyen-Ogooué province, Gabon; evidence of the presence of dengue serotype 1.
- Author
-
Bikangui, Rodrigue, Parkouda, Soulemane, More, Ayong, Magossou Mbadinga, Marien Veraldy, Boussoukou, Ismael Piérrick Mikelet, Ondo, Georgelin Nguema, Nkoma, Anne Marie Mouina, Adamou, Rafiou, Honkpehedji, Yabo Josiane, Rossatanga, Elie Gide, Ushijima, Yuri, Abe, Haruka, Lell, Bertrand, Dejon-Agobé, Jean Claude, Yasuda, Jiro, and Adegnika, Ayola Akim
- Subjects
- *
DENGUE , *DENGUE viruses , *SEROTYPES , *SYMPTOMS , *BLOOD collection , *APPETITE loss , *COUGH , *FENITROTHION - Abstract
Background: Despite dengue virus (DENV) outbreak in Gabon a decade ago, less is known on the potential circulation of DENV serotypes in the country. Previous studies conducted in some areas of the country, are limited to hospital-based surveys which reported the presence of some cases of serotype 2 and 3 seven years ago and more recently the serotype 1. As further investigation, we extend the survey to the community of Moyen Ogooué region with the aim to assess the presence of the dengue virus serotypes, additionally to characterize chikungunya (CHIKV) infection and describe the symptomatology associated with infections. Method: A cross-sectional survey was conducted from April 2020 to March 2021. The study included participants of both sexes and any age one year and above, with fever or history of fever in the past seven days until blood collection. Eligible volunteers were clinically examined, and blood sample was collected for the detection of DENV and CHIKV using RT-qPCR. Positive samples were selected for the target sequencing. Results: A total of 579 volunteers were included. Their mean age (SD) was 20 (20) years with 55% of them being female. Four cases of DENV infection were diagnosed giving a prevalence of 0.7% (95%CI: 0.2–1.8) in our cohort while no case of CHIKV was detected. The common symptoms and signs presented by the DENV cases included fatigue, arthralgia myalgia, cough, and loss of appetite. DENV-1was the only virus detected by RT-qPCR. Conclusion: Our results confirm the presence of active dengue infection in the region, particularly DENV-1, and could suggest the decline of DENV-2 and DENV-3. Continuous surveillance remains paramount to comprehensively describe the extent of dengue serotypes distribution in the Moyen-Ogooué region of Gabon. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
25. Giant Intraabdominal Lymphangioma in a Pediatric Patient—A Challenging Diagnosis.
- Author
-
Candussi, Iuliana-Laura, Petecariu, Alexandru, Lungu, Mirela, Busila, Camelia, Mihailov, Raul, Neagu, Anca, Lungu, Claudiu N., Sarbu, Ioan, and Ciongradi, Carmen I.
- Subjects
- *
CHILD patients , *LYMPHANGIOMAS , *DIAGNOSIS , *SYMPTOMS , *APPETITE loss - Abstract
Introduction: Intra-abdominal cystic formations represent heterogeneous pathologies with varied localization and clinical manifestation. The first challenge of a giant intra-abdominal cystic lesion is identifying the organ of origin. The clinical presentation of intra-abdominal cystic lesions varies from acute manifestations to non-specific symptoms or accidental discovery. Case presentation: A 2-year-old girl presents to the emergency unit with a fever of 38.5 Celsius, loss of appetite, and apathy. The investigations showed a gigantic intra-abdominal mass whose organ belonging could not be specified. Postoperatively, a giant mesenteric lymphangioma was evident, which was completely excised. Discussion: Giant cystic formations modify the anatomical reports and become space-replacing formations, and the starting point is even more challenging to assess preoperatively. Nevertheless, the careful evaluation of the characteristics of the formation, the effect on the adjacent organs, the age of the patient, and the clinical picture can provide elements of differential diagnosis. The stated purpose of this work is to systematize intra-abdominal lesions according to the organ of origin and to make the preoperative diagnosis of an intra-abdominal cystic lesion in the pediatric patient easy to perform starting from the presented case. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
26. Hidden in plain sight – Survival consequences of baseline symptom burden in women with recurrent ovarian cancer.
- Author
-
Roncolato, Felicia, King, Madeleine T., O'Connell, Rachel L., Lee, Yeh Chen, Joly, Florence, Hilpert, Felix, Lanceley, Anne, Yoshida, Yoshio, Bryce, Jane, Donnellan, Paul, Oza, Amit, Avall-Lundqvist, Elisabeth, Berek, Jonathan S., Ledermann, Jonathan A., Berton, Dominique, Sehouli, Jalid, Kaminsky, Marie-Christine, Stockler, Martin R., and Friedlander, Michael
- Subjects
- *
SYMPTOM burden , *OVARIAN cancer , *PROGRESSION-free survival , *GYNECOLOGIC cancer , *APPETITE loss - Abstract
To describe the baseline symptom burden(SB) experienced by patients(pts) with recurrent ovarian cancer(ROC) prior and associations with progression free survival (PFS) and overall survival (OS). We analysed baseline SB reported by pts. with platinum resistant/refractory ROC (PRR-ROC) or potentially‑platinum sensitive ROC receiving their third or greater line of chemotherapy (PPS-ROC≥3) enrolled in the Gynecologic Cancer InterGroup - Symptom Benefit Study (GCIG-SBS) using the Measure of Ovarian Symptoms and Treatment concerns (MOST). The severity of baseline symptoms was correlated with PFS and OS. The 948 pts. reported substantial baseline SB. Almost 80% reported mild to severe pain, and 75% abdominal symptoms. Shortness of breath was reported by 60% and 90% reported fatigue. About 50% reported moderate to severe anxiety, and 35% moderate to severe depression. Most (89%) reported 1 or more symptoms as moderate or severe, 59% scored 6 or more symptoms moderate or severe, and 46% scored 9 or more symptoms as moderate or severe. Higher SB was associated with significantly shortened PFS and OS; five symptoms had OS hazard ratios larger than 2 for both moderate and severe symptom cut-offs (trouble eating, vomiting, indigestion, loss of appetite, and nausea; p < 0.001). Pts with ROC reported high SB prior to starting palliative chemotherapy, similar among PRR-ROC and PPS-ROC≥3. High SB was strongly associated with early progression and death. SB should be actively managed and used to stratify patients in clinical trials. Clinical trials should measure and report symptom burden and the impact of treatment on symptom control. • Patients with recurrent ovarian cancer report a high symptom burden at baseline prior to commencing chemotherapy. • The high symptom burden is not reflected by performance status alone. • High symptom burden is strongly associated with early progression and death. • Symptom burden should be documented, actively managed and used to stratify patients in clinical trials. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
27. Splenic Myelolipomas in the Domestic Cat—To Operate or Not to Operate?
- Author
-
Kennedy, Diana J., Ferreira, Helena M. T., Dobromylskyj, Melanie J., Hobi, Stefan, Almendros, Angel, and Bęczkowski, Paweł M.
- Subjects
- *
CATS , *APPETITE loss , *POSTOPERATIVE period , *BENIGN tumors , *ABDOMINAL pain , *SYMPTOMS , *WEIGHT loss - Abstract
Simple Summary: Myelolipoma of the spleen is a benign tumour rarely described in cats. These masses typically do not spread to other organs, but their growth can push or displace surrounding tissues and lead to pain or discomfort. In this report we describe a cat that presented to the veterinarian with a history of poor appetite and weight loss. Following thorough diagnostic investigations, presenting complaints were attributed to the intra-abdominal growth of a splenic mass. The mass was removed surgically, but the patient died in the recovery period. This case report highlights the need for careful assessment of a risk–benefit ratio when approaching this rare form of neoplasm in cats. Myelolipoma is a benign, typically inert neoplasm of uncertain aetiology that is rarely reported in cats. Although commonly asymptomatic, in some cases, myelolipomas can cause abdominal discomfort or present with rupture and haemorrhage. Here, we describe a rare case of a splenic myelolipoma in a Domestic Long Hair cat in which, after extensive diagnostic investigations, clinical signs of hyporexia and weight loss were attributable to the presence of an intra-abdominal mass. The patient was treated by splenectomy and unexpectedly died during the post-operative period. Although splenectomy appears to be a sensible intervention in symptomatic patients, the optimal management of splenic myelolipomas in cats remains unknown. The risk–benefit ratio of surgical management needs to be carefully considered, and therapeutic intervention should be tailored individually to each patient. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
28. Health-related Quality of Life in Patients with Previously Treated Advanced Urothelial Carcinoma from EV-301: A Phase 3 Trial of Enfortumab Vedotin Versus Chemotherapy.
- Author
-
Rosenberg, Jonathan E., Mamtani, Ronac, Sonpavde, Guru P., Loriot, Yohann, Duran, Ignacio, Lee, Jae-Lyun, Matsubara, Nobuaki, Vulsteke, Christof, Castellano, Daniel, Sridhar, Srikala S., Pappot, Helle, Gurney, Howard, Bedke, Jens, van der Heijden, Michiel S., Galli, Luca, Keam, Bhumsuk, Masumori, Naoya, Meran, Johannes, O'Donnell, Peter H., and Park, Se Hoon
- Subjects
- *
CLINICAL trials , *TRANSITIONAL cell carcinoma , *QUALITY of life , *APPETITE loss , *PATIENTS' attitudes , *PSYCHO-oncology , *PAIN - Abstract
Health-related quality-of-life (HRQoL) was maintained in patients across enfortumab vedotin (EV) treatment. Patients treated with EV had significant reductions in pain but had more appetite loss in comparison to patients treated with chemotherapy, and they had confirmed improvements in multiple HRQoL domains. In comparison to chemotherapy, enfortumab vedotin (EV) prolonged overall survival in patients with previously treated advanced urothelial carcinoma in EV-301. The objective of the present study was to assess patient experiences of EV versus chemotherapy using patient-reported outcome (PRO) analysis of health-related quality of life (HRQoL). For patients in the phase 3 EV-301 trial randomized to EV or chemotherapy we assessed responses to the validated European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 (QLQ-C30) at baseline, weekly for the first 12 wk, and then every 12 wk until discontinuation. We analyzed the QLQ-C30 change from baseline to week 12, the confirmed improvement rate, and the time to improvement or deterioration. Baseline PRO compliance rates were 91% for the EV arm (n = 301) and 89% for the chemotherapy arm (n = 307); the corresponding average rates from baseline to week 12 were 70% and 67%. Patients receiving EV versus chemotherapy had reduced pain (difference in change from baseline to week 12: −5.7, 95% confidence interval [CI] −10.8 to −0.7; p = 0.027) and worsening appetite loss (7.3, 95% CI 0.90–13.69; p = 0.026). Larger proportions of patients in the EV arm reported HRQoL improvement from baseline than in the chemotherapy arm; the odds of a confirmed improvement across ten QLQ-C30 function/symptom scales were 1.67 to 2.76 times higher for EV than for chemotherapy. Patients in the EV arm had a shorter time to first confirmed improvement in global health status (GHS)/QoL, fatigue, pain, and physical, role, emotional, and social functioning (all p < 0.05). EV delayed the time to first confirmed deterioration in GHS/QoL (p = 0.027), but worsening appetite loss occurred earlier (p = 0.009) in comparison to chemotherapy. HRQoL with EV was maintained, and deterioration in HRQoL was delayed with EV in comparison to chemotherapy. Better results with EV were reported for some scales, with the greatest difference observed for pain. These findings reinforce the EV safety and efficacy outcomes and benefits observed in EV-301. Patients with previously treated advanced cancer of the urinary tract receiving the drug enfortumab vedotin maintained their HRQoL in comparison to patients treated with chemotherapy. The EV-301 trial is registered on ClinicalTrials.gov as NCT03474107 and on EudraCT as 2017-003344-21. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
29. Effect of Morin on Lipopolysaccharides-Induced Acute Kidney Injury in Mice.
- Author
-
Mohamed, Aya M., Mahmoud, Yomna I., Amin, Basma H., Mahmoud, Asmaa A., and Fares, Nagui H.
- Subjects
- *
ACUTE kidney failure , *RENAL replacement therapy , *INTENSIVE care units , *HINDLIMB , *APPETITE loss - Abstract
Introduction: Sepsis is a serious complaint caused by a dysregulated host response to infection. It is one of the most common causes of admission to intensive care units. Acute kidney injury (AKI) is the most frequent complication of sepsis in critically ill patients and often requires renal replacement therapy. Despite decades of sepsis research, no specific therapies for sepsis emerged. Morin is a flavonoid that is abundant in the plants of the Moraceae famil, and has protective effect against many diseases that are mostly affected by inflammation and overproduction of oxidative stress, including a range of nephrotoxicity models rather than septic-induced AKI. Aim of the Study: Thus, the present study was carried out to evaluate the effect of morin on the survival rate, clinical symptoms, renal histological alterations, and the immunoreactivity of the cell survival marker BCl2 in septic-induced AKI. Methods: sepsis-induced AKI was induced in mice by a single intraperitoneal injection of lipopolysaccharides (LPS;5mg/kg). Treatment with morin (50 mg/kg bw) started 5 hours after LPS challenge, then for 2 more days. Results: The results showed that LPS-injected mice had low survival rate (44% vs 100% in normal control) and showed several clinical signs including;hypoactivity, lethargy, loss of appetite, ruffled fur, high breathing rate, hind limb paralysis, and closed eyes. On the other hand, morin-treated animals showed significantly higher survival rate than that of the septic control group (90% vs 44%), recovery from the signs of sepsis, enhancement of the histology of kidney. In addition, morin decreased the immunoreactivity of the cell surviving marker BCl2. Conclusion: these findings indicate that morin has a notable therapeutic effect against sepsis-associated AKI and may be a useful therapeutic option for increasing the survival rates of septic patients or even for preventing its associated renal complications. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
30. The influence of delayed gastric emptying on quality of life after partial duodenopancreatectomy.
- Author
-
Klein, Marie, Warschkow, Rene, Ukegjini, Kristjan, Krstic, Daniel, Burri, Pascal, Chatziisaak, Dimitrios, Steffen, Thomas, Schmied, Bruno, Probst, Pascal, and Tarantino, Ignazio
- Subjects
- *
GASTRIC emptying , *PANCREATICODUODENECTOMY , *QUALITY of life , *PSYCHOSOCIAL functioning , *PANCREATIC surgery , *APPETITE loss - Abstract
Purpose: Quality of life (QoL) is temporarily compromised after pancreatic surgery, but no evidence for a negative impact of postoperative complications on QoL has been provided thus far. Delayed gastric emptying (DGE) is one of the most common complications after pancreatic surgery and is associated with a high level of distress. Therefore, the aim of this study was to analyse the influence of DGE on QoL. Methods: This single-centre retrospective study analysed QoL after partial duodenopancreatectomy (PD) via the European Organization for Research and Treatment of Cancer core questionnaire (QLQ-C30). The QoL of patients with and without postoperative DGE was compared. Results: Between 2010 and 2022, 251 patients were included, 85 of whom developed DGE (34%). Within the first postoperative year, compared to patients without DGE, those with DGE had a significantly reduced QoL, by 9.0 points (95% CI: -13.0 to -5.1, p < 0.001). Specifically, physical and psychosocial functioning (p = 0.020) decreased significantly, and patients with DGE suffered significantly more from fatigue (p = 0.010) and appetite loss (p = 0.017) than patients without DGE. After the first postoperative year, there were no significant differences in QoL or symptom scores between patients with DGE and those without DGE. Conclusion: Patients who developed DGE reported a significantly reduced QoL and reduced physical and psychosocial functioning within the first year after partial pancreatoduodenectomy compared to patients without DGE. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
31. Immunohistochemical Localization of Leptin and Ghrelin in Kidney Tissue of Capsaicin Administered Diabetic and Non-diabetic Rats.
- Author
-
BİNGÖL, Seyit Ali, DEPREM, Turgay, İLHAN AKSU, Serap, KORAL TAŞÇI, Serap, ERMUTLU, Dilem Gülece, and ASLAN, Şahin
- Subjects
- *
LEPTIN , *CAPSAICIN , *GHRELIN , *RATS , *APPETITE loss , *BLOOD sugar - Abstract
In this study, we investigated the effect of Capsaicin (CAP) on leptin and ghrelin expression in diabetic kidneys by immunohistochemical method. The subjects were separated into 5 groups: control, sham, diabetes, CAP, and D+CAP. Streptozotocin (45 mg/kg, single dose) was administered to each rat in the diabetes and D+CAP groups intraperitoneally. Rats with blood glucose levels of200 mg/dL or higher were considered diabetic. Capsaicin (1 mg/kg) was administered subcutaneously to the rats in the CAP and D+CAP groups every day for 2 weeks. H&E, PAS, and Crossman's Triple staining were performed to examine the histology of the kidney. Leptin and ghrelin in the kidney were examined by immunohistochemical method. Histological examination revealed normal kidney tissue in the control, sham, and CAP groups. The diabetes group showed the glomerulus with scattered and narrowing of the Bowman's capsule. While leptin immunoreactivity was most intense in the diabetes group, it was observed the weakest in the CAP and D+CAP groups. While strong ghrelin immunoreactivity was seen in the control and sham groups, mild immunoreactivity was seen in the CAP group, and weak immunoreactivity was seen in the diabetes and D+CAP groups. In this study, we concluded that the application of CAP could prevent loss of appetite by reducing the leptin expression during diabetes, but could not protect ghrelin from adverse effects of diabetes. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
32. A Long-Term Study Comparing the Quality of Life and Psychological Status of Patients with Highly Suspicious Thyroid Nodules ≤1 cm Undergoing Active Surveillance with Those Undergoing Immediate Surgery.
- Author
-
Liu, Chunhao, Zhao, Hao, Lu, Ying, Xia, Yu, Cao, Yue, Zhang, Liyang, Zhao, Ya, Gao, Luying, Liu, Yuewu, Liu, Hongfeng, Kuang, Zifeng, Liu, Shuzhou, Shao, Qianqian, and Li, Xiaoyi
- Subjects
- *
THYROID nodules , *WATCHFUL waiting , *QUALITY of life , *APPETITE loss , *FINANCIAL stress , *LARYNGOPLASTY - Abstract
Background: Limited information is available on the long-term impact of active surveillance (AS) and immediate surgery (IS) on the quality of life (QoL) and psychological status of patients with highly suspicious subcentimeter thyroid nodules. Methods: A prospective study was conducted on 752 patients showing highly suspicious subcentimeter thyroid nodules, among whom 584 chose AS and 168 chose IS. All patients underwent at least two assessments regarding their QoL and psychological status, using three questionnaires: Thyroid Cancer-Specific Quality of Life (THYCA-QoL), Hospital Anxiety and Depression Scale (HADS), and European Organization for Research and Treatment of Cancer (EORTC) Quality of Life Core Questionnaire (QLQ-C30). Propensity-score matching (PSM) at a ratio of 3:1 was utilized on patients in the AS and IS groups to mitigate selection bias (504 patients in the AS group and 168 in the IS group). Subsequently, the mixed linear model was used to analyze the QoL data. Results: The median time from the initial evaluation to the last follow-up in the AS and IS groups was 24.0 and 14.2 months, respectively. The AS group showed superior QoL outcomes compared to the IS group, mainly manifested in voice (p < 0.001), sympathetic (p = 0.008), throat/mouth (p < 0.001), and problems with scar (p < 0.001) domains, as per the THYCA-QoL questionnaire. Further, the EORTC QLQ-C30 questionnaire highlighted better outcomes in physical function (p = 0.029), role function (p < 0.001), social function (p < 0.001), global health status (p < 0.001), fatigue (p = 0.012), pain (p = 0.028), appetite loss (p = 0.017), and financial difficulties (p < 0.001). Compared to the initial assessment (1 week after surgery), the IS group showed progressive improvements in QoL, especially in voice (p = 0.024), throat/mouth (p < 0.001), physical function (p = 0.004), social function (p = 0.014), nausea and vomiting (p < 0.001), pain (p = 0.006), and appetite loss (p = 0.048) domains as per both questionnaires. Conclusion: Patients with highly suspicious subcentimeter thyroid nodules who choose IS tend to experience a poorer long-term QoL compared to those who choose AS. Although the situation may improve over time, certain issues might persist, making AS a favorable option for these patients. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
33. Should Cannabis be Used for Anorexia in Patients With Cancer?
- Author
-
Davis, Mellar, Cyr, Claude, Crawford, Gregory B., and Case, Amy A.
- Subjects
- *
CANCER patients , *APPETITE loss , *MEDICAL personnel , *DRUG interactions , *SYNTHETIC products - Abstract
Healthcare professionals are frequently asked about the benefits of cannabis for appetite or anorexia-cachexia syndrome. In popular culture, cannabis has a reputation of causing an increased hunger, slang termed "the munchies," so many patients consume this with the hope that it may improve the loss of appetite associated with serious illness such as cancer. There have only been a few randomized, controlled trials studying the controversial question as to if cannabis improves appetite. These studies are small and show no statistically significant benefit for appetite and one small study showed improvement of taste for foods. Due to regulation barriers, the studies have use synthetic products, not the products that represent what is more commonly used in the population, often whole flower smoked, vaporized or oral products. Despite the popularity of cannabis in culture, often touted as a panacea for all maladies, the evidence and education for several adverse effects and potential drug interactions have has yet to catch up with the cultural craze. International cannabis experts in the United States and Australia do not routinely certify patients for medical cannabis off trial for anorexia-cachexia, but one expert in Canada would consider use in selected cancer patients. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
34. Health-related quality of life in patients with newly diagnosed advanced ovarian cancer treated with niraparib vs placebo: Results from the phase 3 randomized PRIMA/ENGOT-OV26/GOG-3012 trial.
- Author
-
Pothuri, Bhavana, Han, Sileny, Chase, Dana M., Heitz, Florian, Burger, Robert A., Gaba, Lydia, Van Le, Linda, Guerra, Eva, Bender, David, Korach, Jacob, Cloven, Noelle, Churruca, Cristina, Follana, Philippe, DiSilvestro, Paul, Baurain, Jean-François, Jardon, Kris, Pisano, Carmela, Peen, Ulla, Mäenpää, Johanna, and Gupta, Divya
- Subjects
- *
QUALITY of life , *OVARIAN cancer , *APPETITE loss , *FATIGUE (Physiology) , *PLACEBOS - Abstract
To assess patient-reported health-related quality of life (HRQoL) in patients with ovarian cancer (OC) who received niraparib as first-line maintenance therapy. PRIMA/ENGOT-OV26/GOG-3012 (NCT02655016) enrolled patients with newly diagnosed advanced OC who responded to first-line platinum-based chemotherapy. Patients were randomized (2:1) to niraparib or placebo once daily in 28-day cycles until disease progression, intolerable toxicity, or death. HRQoL was assessed as a prespecified secondary end point using patient-reported responses to the European Organisation for Research and Treatment of Cancer QOL Questionnaire (EORTC QLQ-C30), the EORTC QLQ Ovarian Cancer Module (EORTC QLQ-OV28), the Functional Assessment of Cancer Therapy–Ovarian Symptom Index (FOSI), and EQ-5D-5L questionnaires. Assessments were collected at baseline and every 8 weeks (±7 days) for 56 weeks, beginning on cycle 1/day 1, then every 12 weeks (±7 days) thereafter while the patient received study treatment. Among trial participants (niraparib, n = 487; placebo, n = 246), PRO adherence exceeded 80% for all instruments across all cycles. Patients reported no decline over time in HRQoL measured via EORTC QLQ-C30 Global Health Status/QoL and FOSI overall scores. Scores for abdominal/gastrointestinal symptoms (EORTC QLQ-OV28) and nausea and vomiting, appetite loss, and constipation (EORTC QLQ-C30) were higher (worse symptoms) in niraparib-treated patients than placebo-treated patients; except for constipation, these differences resolved over time. Patients did not self-report any worsening from baseline of fatigue, headache, insomnia, or abdominal pain on questionnaires. Despite some early, largely transient increases in gastrointestinal symptoms, patients with OC treated with niraparib first-line maintenance therapy reported no worsening in overall HRQoL. [Display omitted] • Detailed analysis of patient-reported outcomes from the PRIMA trial of niraparib as a first-line maintenance therapy. • Compared with placebo, niraparib-treated patients self-reported worse symptoms of constipation, nausea/vomiting, and appetite loss. • Except for constipation, the increase in gastrointestinal symptoms compared with placebo resolved over time. • No worsening of fatigue, headache, insomnia, or abdominal pain over time were noted on self-reported questionnaires. • Overall quality of life was generally maintained with niraparib treatment despite patient-reported gastrointestinal symptoms. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
35. Analysis of non-motor symptoms in amyotrophic lateral sclerosis.
- Author
-
Shojaie, Ali, Al Khleifat, Ahmad, Sarraf, Payam, and Al-Chalabi, Ammar
- Subjects
- *
AMYOTROPHIC lateral sclerosis , *SOCIAL media , *APPETITE loss , *DOWNLOADING , *SYMPTOMS - Abstract
We investigated non-motor symptoms in ALS using sequential questionnaires; here we report the findings of the second questionnaire. A social media platform (Twitter, now known as X) was used to publicize the questionnaires. Data were downloaded from SurveyMonkey and analyzed by descriptive statistics, comparison of means, and regression models. There were 182 people with ALS and 57 controls. The most important non-motor symptoms were cold limbs (60.4% cases, 14% controls, p = 9.67 x 10−10) and appetite loss (29.7% cases, 5.3% controls, p = 1.6 x 10−4). The weaker limb was most likely to feel cold (p = 9.67 x 10−10), and symptoms were more apparent in the evening and night. Appetite loss was reported as due to feeling full and the time taken to eat. People with ALS experienced medium-intensity pain, more usually shock-like pain than burning or cold-like pain, although the most prevalent type of pain was non-differentiated. Non-motor symptoms are an important feature of ALS. Further investigation is needed to understand their physiological basis and whether they represent phenotypic differences useful for subtyping ALS. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
36. Effect of Transcutaneous Electrical Nerve Stimulation of T6 Dermatome on Appetite and Weight Reduction in Obese Individuals: A Pilot Study.
- Author
-
Sahu, Pradeep Kumar, Ranjan, Piyush, Agrawal, Deepak, and Singh, Garima
- Subjects
- *
TRANSCUTANEOUS electrical nerve stimulation , *WEIGHT loss , *APPETITE loss , *ELECTRIC stimulation , *VISUAL analog scale - Abstract
Background: Previous work demonstrated the beneficial effect of T6 dermatomal stimulation by the percutaneous method in managing obesity. However, a simple, cost-effective, and feasible intervention stimulating the dermatome can be a potential solution for obesity care. Objective: The objective of this study was to find the effect of transcutaneous electrical nerve stimulation (TENS) of T6 dermatome on appetite and weight loss in obese individuals. Material and Methods: In this prospective single-arm experimental study, 20 obese patients received TENS treatment of T6 dermatome for 30 min, once a week and for 12 weeks. Outcome measures such as appetite level in the visual analog scale (VAS), weight in kg, and basal metabolic index (BMI) in kg/m2 were assessed at baseline, 12 weeks -post-intervention, and at 8 weeks of follow-up. Results: A statistically significant difference in all the variables was found from baseline to 12 weeks of intervention (P < 0.001) and maintained till 8 weeks of follow-up. From pre- to post-treatment, the effect size for appetite reduction was large (>1) while for weight and BMI loss was (0.14, 0.16), respectively small. Additionally, a weak correlation was found between pre- and follow-up appetite and weight loss (r = 0.25, P = 0.294). Conclusions Twelve weeks of TENS treatment of T6 dermatome showed a positive effect in reducing appetite with sustained reduction up to 8 weeks of follow-up even after completion of the intervention. However, in the absence of dietary modification, TENS treatment was associated with low effect sizes weight and BMI loss. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
37. Adult type I Gaucher disease with splenectomy caused by a compound heterozygous GBA1 mutation in a Chinese patient: a case report.
- Author
-
Zhang, Jian-hui, Chen, Hui, Ruan, Dan-dan, Chen, Ying, Zhang, Li, Gao, Mei-zhu, Chen, Qian, Yu, Hong-ping, Wu, Jia-yi, Lin, Xin-fu, Fang, Zhu-ting, Zheng, Xiao-ling, Luo, Jie-wei, Liao, Li-sheng, and Li, Hong
- Subjects
- *
GAUCHER'S disease , *SPLENECTOMY , *GENETIC mutation , *APPETITE loss , *DELAYED diagnosis , *GRANULOSA cell tumors , *GLYCOGEN storage disease type II - Abstract
Gaucher disease (GD) is an autosomal recessive ailment resulting from glucocerebrosidase deficiency caused by a mutation in the GBA1 gene, leading to multi-organ problems in the liver, spleen, and bone marrow. In China, GD is extremely uncommon and has a lower incidence rate than worldwide. In this study, we report the case of an adult male with an enlarged spleen for 13 years who presented with abdominal distension, severe loss of appetite and weight, reduction of the three-line due to hypersplenism, frequent nosebleeds, and bloody stools. Regrettably, the unexpected discovery of splenic pathology suggestive of splenic Gaucher disease was only made after a splenectomy due to a lack of knowledge about rare disorders. Our patient's delayed diagnosis may have been due to the department where he was originally treated, but it highlights the need for multidisciplinary consultation in splenomegaly of unknown etiology. We then investigated the patient's clinical phenotypes and gene mutation features using genetically phenotypical analysis. The analysis of the GBA1 gene sequence indicated that the patient carried a compound heterozygous mutation consisting of two potentially disease-causing mutations: c.907C > A (p. Leu303Ile) and c.1448 T > C (p. Leu483Pro). While previous research has linked the p. Leu483Pro mutation site to neurologic GD phenotypes (GD2 and GD3), the patients in this investigation were identified as having non-neuronopathic GD1. The other mutation, p. Leu303Ile, is a new GD-related mutation not indexed in PubMed that enriches the GBA1 gene mutation spectrum. Biosignature analysis has shown that both mutations alter the protein's three-dimensional structure, which may be a pathogenic mechanism for GD1 in this patient. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
38. Pseudomyxoma peritonei: The struggle of a lifetime and the hope of a cure - a rare diagnosis with review of the literature.
- Author
-
Askar, Ahmet, Arpat, Asli, and Durgun, Vedat
- Subjects
RARE diseases ,COMPUTED tomography ,APPETITE loss ,HYPERTHERMIC intraperitoneal chemotherapy ,ABDOMINAL pain - Abstract
Pseudomyxoma peritonei is a rare pathological condition characterized by mucinous tumor tissue implants on the peritoneal surface. Although the cause of Pseudomyxoma peritonei has been extensively studied, the prevailing agreement is that it stems from mucinous tumors that occur in the ovaries or appendix. The tumor tissue typically remains localized to the peritoneum and does not exhibit extraperitoneal spread. Patients with Pseudomyxoma peritonei may present with symptoms such as abdominal pain, bloating, loss of appetite, and shortness of breath. Computerized Tomography is commonly used for diagnostic purposes. The treatment of Pseudomyxoma peritonei typically involves surgical evacuation of the tumoral tissue, followed by cytoreduction and Hyperthermic Intraperitoneal Chemotherapy. While effective treatment options are available, some patients may require repeated surgeries over an extended period. This paper reports on a case study of a patient with a history of recurrent Pseudomyxoma peritonei, necessitating multiple surgical interventions over a decade. The paper concludes with a review of the relevant literature. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
39. Endoscopic manifestation of intestinal transplant-associated microangiopathy after stem cell transplantation.
- Author
-
Iwamuro, Masaya, Ennishi, Daisuke, Fujii, Nobuharu, Matsuoka, Ken-ichi, Tanaka, Takehiro, Inokuchi, Toshihiro, Hiraoka, Sakiko, and Otsuka, Motoyuki
- Subjects
- *
STEM cell transplantation , *GASTROINTESTINAL mucosa , *IRRITABLE colon , *SHORT bowel syndrome , *INTESTINES , *APPETITE loss , *GASTROINTESTINAL system - Abstract
Background: Endoscopic features of intestinal transplant-associated microangiopathy (iTAM) have not been comprehensively investigated. This study aimed to examine the endoscopic characteristics of patients diagnosed with iTAM. Methods: This retrospective analysis included 14 patients pathologically diagnosed with iTAM after stem cell transplantation for hematolymphoid neoplasms (n = 13) or thalassemia (n = 1). The sex, age at diagnosis, endoscopic features, and prognosis of each patient were assessed. Serological markers for diagnosing transplant-associated thrombotic microangiopathy were also evaluated. Results: The mean age at the time of iTAM diagnosis was 40.2 years. Patients diagnosed based on the pathognomonic pathological changes of iTAM presented with diverse symptoms at the times of endoscopic examinations, including diarrhea (n = 10), abdominal pain (n = 5), nausea (n = 4), appetite loss (n = 2), bloody stools (n = 2), abdominal discomfort (n = 1), and vomiting (n = 1). At the final follow-up, six patients survived, while eight patients succumbed, with a median time of 100.5 days (range: 52–247) post-diagnosis. Endoscopic manifestations included erythematous mucosa (n = 14), erosions (n = 13), ulcers (n = 9), mucosal edema (n = 9), granular mucosa (n = 9), and villous atrophy (n = 4). Erosions and/or ulcers were primarily observed in the colon (10/14, 71%), followed by the ileum (9/13, 69%), stomach (4/10, 40%), cecum (5/14, 36%), duodenum (3/10, 30%), rectum (4/14, 29%), and esophagus (1/10, 10%). Cytomegalovirus infection (n = 4) and graft-versus-host disease (n = 2) coexisted within the gastrointestinal tract. Patients had de novo prolonged or progressive thrombocytopenia (6/14, 43%), decreased hemoglobin concentration (4/14, 29%), reduced serum haptoglobin level (3/14, 21%), and a sudden and persistent increase in lactate dehydrogenase level (2/14, 14%). Peripheral blood samples from 12 patients were evaluated for schistocytes, with none exceeding 4%. Conclusions: This study provides a comprehensive exploration of the endoscopic characteristics of iTAM. Notably, all patients exhibited erythematous mucosa throughout the gastrointestinal tract, accompanied by prevalent manifestations, such as erosions (93%), ulcers (64%), mucosal edema (64%), granular mucosa (64%), and villous atrophy (29%). Because of the low positivity for serological markers of transplant-associated thrombotic microangiopathy in patients with iTAM, endoscopic evaluation and biopsy of these lesions are crucial, even in the absence of these serological features. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
40. Characterization of an African Swine Fever Virus Field Isolate from Vietnam with Deletions in the Left Variable Multigene Family Region.
- Author
-
Ambagala, Aruna, Goonewardene, Kalhari, Kanoa, Ian El, Than, Thi Tam, Nguyen, Van Tam, Lai, Thi Ngoc Ha, Nguyen, Thi Lan, Erdelyan, Cassidy N. G., Robert, Erin, Tailor, Nikesh, Onyilagha, Chukwunonso, Lamboo, Lindsey, Handel, Katherine, Nebroski, Michelle, Vernygora, Oksana, Lung, Oliver, and Le, Van Phan
- Subjects
- *
AFRICAN swine fever , *AFRICAN swine fever virus , *APPETITE loss - Abstract
In this paper, we report the characterization of a genetically modified live-attenuated African swine fever virus (ASFV) field strain isolated from Vietnam. The isolate, ASFV-GUS-Vietnam, belongs to p72 genotype II, has six multi-gene family (MGF) genes deleted, and an Escherichia coli GusA gene (GUS) inserted. When six 6–8-week-old pigs were inoculated with ASFV-GUS-Vietnam oro-nasally (2 × 105 TCID50/pig), they developed viremia, mild fever, lethargy, and inappetence, and shed the virus in their oral and nasal secretions and feces. One of the pigs developed severe clinical signs and was euthanized 12 days post-infection, while the remaining five pigs recovered. When ASFV-GUS-Vietnam was inoculated intramuscularly (2 × 103 TCID50/pig) into four 6-8 weeks old pigs, they also developed viremia, mild fever, lethargy, inappetence, and shed the virus in their oral and nasal secretions and feces. Two contact pigs housed together with the four intramuscularly inoculated pigs, started to develop fever, viremia, loss of appetite, and lethargy 12 days post-contact, confirming horizontal transmission of ASFV-GUS-Vietnam. One of the contact pigs died of ASF on day 23 post-contact, while the other one recovered. The pigs that survived the exposure to ASFV-GUS-Vietnam via the mucosal or parenteral route were fully protected against the highly virulent ASFV Georgia 2007/1 challenge. This study showed that ASFV-GUS-Vietnam field isolate is able to induce complete protection in the majority of the pigs against highly virulent homologous ASFV challenge, but has the potential for horizontal transmission, and can be fatal in some animals. This study highlights the need for proper monitoring and surveillance when ASFV live-attenuated virus-based vaccines are used in the field for ASF control in endemic countries. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
41. Evidence of enteritis, hepatic steatosis and jaundice in juvenile pirarucu (Arapaima gigas) fed high levels of soybean meal.
- Author
-
da Silva, Renata Maria, Peres, Helena, Fernández-Boo, Sergio, Barcellos, José Fernando Marques, and Marcon, Jaydione Luiz
- Subjects
- *
FISH feeds , *SOYBEAN meal , *FATTY liver , *ENTERITIS , *JAUNDICE , *APPETITE loss - Abstract
This study evaluated the effects of replacing dietary fishmeal with increasing levels of soybean meal (0, 15, 30, 45 and 60% corresponding to 0, 11, 22, 33 and 44% inclusion in the formulated diet) on the intestine and liver histomorphology of juvenile pirarucu Arapaima gigas (233 ± 12 g; mean ± SD) fed for 120 days. At the end of the feeding trial, fish fed diets with higher soybean levels (45 and 60%) presented clinical signs such as appetite loss, cachexia and jaundice. In addition, fish fed on 45% and 60% soybean meal had histomorphological alterations in the middle and posterior portions of the intestinal mucosa (enteritis) and high liver lipid deposition (steatosis). Therefore, 45% or 60% of soybean meal is not recommended; however, a replacement of fishmeal by soybean meal of up to 30% (22% inclusion) can be used in diets to feed juvenile pirarucu for long periods. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
42. An 88-Year-Old Woman With Pneumothorax and Black Pleural Effusion.
- Author
-
Takenaka, Shota, Yoshimura, Masayo, Kinoshita, Yoshiaki, Utsunomiya, Takuhide, Kushima, Hisako, Nimura, Satoshi, and Ishii, Hiroshi
- Subjects
- *
IRON deficiency anemia , *BLACK women , *APPETITE loss , *PLEURAL effusions , *COMPUTED tomography , *KIDNEY tumors - Abstract
An 88-year-old woman was admitted to our hospital with the sudden onset of dyspnea after eating. The patient had undergone nephrectomy for a left renal tumor 24 years previously. The patient had been prescribed ferrous citrate for iron-deficiency anemia. She complained of appetite loss a few days before admission but had no abdominal pain. CT scan showed no abnormalities in the lungs but a mass in the liver. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
43. Comparison of energy intake in critical illness survivors, general medical patients, and healthy volunteers: A descriptive cohort study.
- Author
-
Viner Smith, Elizabeth, Kouw, Imre W. K., Summers, Matthew J., Louis, Rhea, Trahair, Laurence, O'Connor, Stephanie N., Jones, Karen L., Horowitz, Michael, Chapman, Marianne J., and Chapple, Lee‐anne S.
- Subjects
CRITICALLY ill ,VOLUNTEERS ,THRESHOLD energy ,APPETITE loss ,VOLUNTEER service ,NUTRITION - Abstract
Background: Intensive care unit (ICU) survivors have reduced oral intake; it is unknown whether intake and associated barriers are unique to this group. Objective: To quantify energy intake and potential barriers in ICU survivors compared with general medical (GM) patients and healthy volunteers. Design: A descriptive cohort study in ICU survivors, GM patients, and healthy volunteers. Following an overnight fast, participants consumed a 200 ml test‐meal (213 kcal) and 180 min later an ad libitum meal to measure energy intake (primary outcome). Secondary outcomes; taste recognition, nutrition‐impacting symptoms, malnutrition, and quality of life (QoL). Data are mean ± SD, median (interquartile range [IQR]) or number [percentage]). Results: Twelve ICU survivors (57 ± 17 years, BMI: 30 ± 6), eight GM patients (69 ± 19 years, BMI: 30 ± 6), and 25 healthy volunteers (58 ± 27 years, BMI: 25 ± 4) were included. Recruitment ceased early because of slow recruitment and SARS‐CoV‐2. Energy intake was lower in both patient groups than in health (ICU: 289 [288, 809], GM: 426 [336, 592], health: 815 [654, 1165] kcal). Loss of appetite was most common (ICU: 78%, GM: 67%). For ICU survivors, GM patients and healthy volunteers, respectively, severe malnutrition prevalence; 40%, 14%, and 0%; taste identification; 8.5 [7.0, 11.0], 8.5 [7.0, 9.5], and 8.0 [6.0, 11.0]; and QoL; 60 [40–65], 50 [31–55], and 90 [81–95] out of 100. Conclusions: Energy intake at a buffet meal is lower in hospital patients than in healthy volunteers but similar between ICU survivors and GM patients. Appetite loss potentially contributes to reduced energy intake. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
44. Malignancy smell in the air: widespread eroded, hemorrhagic, and lichenified plaques in an older man.
- Author
-
Ismayilov, Rashad, Uyaroğlu, Oğuz Abdullah, Kapar, Berkay, Özdede, Murat, and Özdemir, Deniz Ateş
- Subjects
APPETITE loss ,WEIGHT loss ,PARANEOPLASTIC syndromes ,CROSS-sectional imaging ,SKIN diseases ,KERATOSIS - Abstract
Copyright of Pamukkale Medical Journal is the property of Pamukkale Journal of Medicine and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
- Published
- 2024
- Full Text
- View/download PDF
45. Eight cases illustrating improved outcomes of individualized low‐dose Kampo therapy in the management of chronic disease associated with spleen deficiency.
- Author
-
Kimura, Yoko, Yamazaki, Mayuko, Miyakawa, Kyohei, Otani, Kahori, and Morinaga, Akinori
- Subjects
- *
APPETITE loss , *BODY mass index , *CHRONIC pain , *RANDOMIZED controlled trials , *IRRITABLE colon , *OTOSCLEROSIS ,JAPANESE herbal medicine - Abstract
This article discusses the use of low-dose Kampo therapy in the management of chronic diseases associated with spleen deficiency. The authors present eight cases in which patients were successfully treated with Kampo prescriptions at doses below the recommended levels. The cases include patients with gastrointestinal disorders, upset stomach, diarrhea, abdominal pain, constipation, and other symptoms. The article suggests that low doses of Kampo medicines may be optimal for patients with chronic diseases and spleen deficiency, as higher doses can lead to gastrointestinal adverse reactions. Experimental evidence also supports the efficacy of low-dose administration in Kampo therapies. [Extracted from the article]
- Published
- 2024
- Full Text
- View/download PDF
46. Fusarium fujikuroi, Mucor racemosus: Sultan Papağanı (Nymphicus hollandicus).
- Author
-
ÖZTÜRK KÖSE, Senem, BOYNUKARA, Banur, and BIYIK, Hacı Halil
- Subjects
- *
NUCLEIC acid isolation methods , *FUNGAL DNA , *APPETITE loss , *MUCOR , *ACADEMIC departments - Abstract
In this study, the stool sample of a cockatiel (Nymphicus hollandicus Kerr, 1972), brought with complaints of loss of appetite, weight loss and bad smell in the stool, was examined mycologically. Serial dilutions of the stool sample were made under aseptic conditions and inoculated into Dichloran Rose-Bengal Chloramphenicol Agar (DRBC) and blood agar media. After incubation, the samples were separated as pure colonies and morphological, microscopic and molecular identifications were made from these pure colonies. Phenol-chloroform isoamylalcohol DNA isolation method was used for molecular identification. PCR amplification from fungal DNAs was carried out at Aydın Adnan Menderes University Biology Department Microbiology Laboratory and by commercial companies as service procurement. Sequencing services were provided by Innopenta Biotechnology and Macrogen Europe. Primers ITS1 (50-TCCGTAGGTGAACCTGCGG-30) / ITS4 (50-TCCTCCGCTTATTGATATGC-30) were used. The nBLAST program was used to identify fungi and species were matched according to their genetic similarity rates. Sequence results were recorded in the GenBank system and added to the culture collection. After molecular studies, Fusarium fujikuroi HBF578 and Mucor racemosus HBB579 strains were identified. When the literature studies were examined, it was seen that the Fusarium fujikuroi HBF578 strain had not been isolated from the Cockatiel before and was reported for the first time in this study. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
47. APPETITE: Plant Protein and Exercise Solutions for the Prevention of Undernutrition in Older Adults.
- Author
-
Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement, Friedrich-Alexander-Universität Erlangen-Nürnberg, and University of Padova
- Published
- 2023
48. Prevalence, country-specific prescribing patterns and determinants of benzodiazepine use in community-residing older adults in 7 European countries.
- Author
-
Lukačišinová, Anna, Reissigová, Jindra, Ortner-Hadžiabdić, Maja, Brkic, Jovana, Okuyan, Betul, Volmer, Daisy, Tadić, Ivana, Modamio, Pilar, Mariño, Eduardo L., Tachkov, Konstantine, Liperotti, Rosa, Onder, Graziano, Finne-Soveri, Harriet, van Hout, Hein, Howard, Elizabeth P., and Fialová, Daniela
- Subjects
OLDER people ,DRUG prescribing ,OLDER patients ,SLEEP ,APPETITE loss - Abstract
Background: The use of benzodiazepines (BZDs) in older population is often accompanied by drug-related complications. Inappropriate BZD use significantly alters older adults' clinical and functional status. This study compares the prevalence, prescribing patterns and factors associated with BZD use in community-dwelling older patients in 7 European countries. Methods: International, cross-sectional study was conducted in community-dwelling older adults (65 +) in the Czech Republic, Serbia, Estonia, Bulgaria, Croatia, Turkey, and Spain between Feb2019 and Mar2020. Structured and standardized questionnaire based on interRAI assessment scales was applied. Logistic regression was used to evaluate factors associated with BZD use. Results: Out of 2,865 older patients (mean age 73.2 years ± 6.8, 61.2% women) 14.9% were BZD users. The highest prevalence of BZD use was identified in Croatia (35.5%), Spain (33.5%) and Serbia (31.3%). The most frequently prescribed BZDs were diazepam (27.9% of 426 BZD users), alprazolam (23.7%), bromazepam (22.8%) and lorazepam (16.7%). Independent factors associated with BZD use were female gender (OR 1.58, 95%CI 1.19–2.10), hyperpolypharmacy (OR 1.97, 95%CI 1.22–3.16), anxiety (OR 4.26, 95%CI 2.86–6.38), sleeping problems (OR 4.47, 95%CI 3.38–5.92), depression (OR 1.95, 95%CI 1.29–2.95), repetitive anxious complaints (OR 1.77, 95%CI 1.29–2.42), problems with syncope (OR 1.78, 95%CI 1.03–3.06), and loss of appetite (OR 0.60, 95%CI 0.38–0.94). In comparison to Croatia, residing in other countries was associated with lower odds of BZD use (ORs varied from 0.49 (95%CI 0.32–0.75) in Spain to 0.01 (95%CI 0.00–0.03) in Turkey), excluding Serbia (OR 1.11, 95%CI 0.79–1.56). Conclusions: Despite well-known negative effects, BZDs are still frequently prescribed in older outpatient population in European countries. Principles of safer geriatric prescribing and effective deprescribing strategies should be individually applied in older BZD users. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
49. Clinical and psychological implications of post-traumatic stress in firefighters: a moderated network study.
- Author
-
Karnick, Aleksandr, Caulfield, Nicole M., Buerke, Morgan, Stanley, Ian, Capron, Daniel, and Vujanovic, Anka
- Subjects
- *
POST-traumatic stress , *POST-traumatic stress disorder , *FIRE fighters , *APPETITE loss , *SUICIDAL ideation - Abstract
Firefighters are frequently exposed to trauma and may experience a unique symptom presentation of post-traumatic stress. Prior research has identified stronger associations between certain post-traumatic stress symptoms (e.g. detachment, intrusions, physiological reactivity) using network analysis. However, little is known about the effects of symptom severity and emergency work-related trauma on symptom networks. The present study probed the network structure of post-traumatic stress symptoms in trauma-exposed firefighters (N = 871) to model the dynamic interactions of psychological symptoms. We developed a network of post-traumatic stress symptoms and a network of post-traumatic stress with clinical covariates and used moderated network modelling to assess the effects of having PTSD and experiencing work-related trauma on the networks. We identified high edge correlations between several nodes (e.g. startle/hypervigilance, internal/external cue avoidance, detachment/lack of interest) and high centrality of detachment, external cue avoidance, and flashbacks. Additionally, having PTSD moderated positive network associations between risk-taking and suicidality and between distorted blame and post-traumatic cognitions. Work-related trauma moderated negative associations between appetite gain and loss and appetite loss and suicidality. Findings suggest that targeting specific symptoms of detachment, external cue avoidance, and flashbacks could allow for the development of effective trauma-informed interventions for these populations. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
50. Giant Liver Hydatid Cyst: A Case Report and Review of the Literature.
- Author
-
Izadpanah, Ahmad, Bananzadeh, Ali Mohammad, Abdollahifard, Gholamreza, Irajie, Cambyz, Asgari, Qasem, Ahmadi, Elham, and Yavari Barhaghtalab, Mohammad Javad
- Subjects
- *
LITERATURE reviews , *ECHINOCOCCOSIS , *LIVER , *COMPUTED tomography , *APPETITE loss , *HEPATIC echinococcosis , *PANCREATIC cysts - Abstract
Cystic echinococcosis (CE) is a parasitic disease caused by the larval stages of Echinococcus and is considered a neglected disease of public health worldwide. CE primarily affects the liver and demonstrates distinctive radiological findings in computed tomography (CT) and ultrasonography (US). Surgery is considered the mainstay of CE treatment. The patient was a 17-year-old man admitted to the Emergency Department of Shahid Faghihi Hospital affiliated with Shiraz University of Medical Sciences with dull right upper quadrant abdominal pain, loss of appetite, abdominal distention, and fullness. An abdominal CT scan revealed a giant hepatic cyst measuring about 24x20x15 cm in the right hepatic lobe (RHL) with a pressure effect on the right kidney, pancreas, and bowel loops. Semi-chevron incision was done and the patient underwent partial precystectomy with capitonnage and omentoplasty. The surgical outcome was uneventful and the patient was discharged on the eighth day after the surgery with the oral Albendazole. Reviewing the literature, our case was the 5th rank according to the size of the recorded published cases. The most common countries where the largest liver hydatid cysts were reported were Greece and Turkey. The most common surgery was the open surgery and the most common incisions were Kocher and then Chevron incisions. When dealing with a huge liver cyst, a high index of suspicion for echinococcal etiology becomes important in endemic areas such as Iran. The choice of treatment for giant hepatic cysts substantially seems to be radical surgery by surgical ablation in general to mitigate the mortality and morbidity rate, because they are at risk of rupture, anaphylaxis, and so forth. (The abstract is too long for a case report [260 words], it should be around 100 words. The part I highlighted can be deleted.) [ABSTRACT FROM AUTHOR]
- Published
- 2024
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.